chr22-27799614-A-ATGC
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The NM_002430.3(MN1):c.929_930insGCA(p.Gln309dup) variant causes a inframe insertion change. The variant allele was found at a frequency of 0.000381 in 1,540,174 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00012 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00041 ( 0 hom. )
Consequence
MN1
NM_002430.3 inframe_insertion
NM_002430.3 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.02
Genes affected
MN1 (HGNC:7180): (MN1 proto-oncogene, transcriptional regulator) Meningioma 1 (MN1) contains two sets of CAG repeats. It is disrupted by a balanced translocation (4;22) in a meningioma, and its inactivation may contribute to meningioma 32 pathogenesis. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP6
Variant 22-27799614-A-ATGC is Benign according to our data. Variant chr22-27799614-A-ATGC is described in ClinVar as [Benign]. Clinvar id is 2349061.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 18 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MN1 | NM_002430.3 | c.929_930insGCA | p.Gln309dup | inframe_insertion | 1/2 | ENST00000302326.5 | NP_002421.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MN1 | ENST00000302326.5 | c.929_930insGCA | p.Gln309dup | inframe_insertion | 1/2 | 1 | NM_002430.3 | ENSP00000304956 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000120 AC: 18AN: 150022Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
18
AN:
150022
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000650 AC: 73AN: 112286Hom.: 0 AF XY: 0.000555 AC XY: 33AN XY: 59458
GnomAD3 exomes
AF:
AC:
73
AN:
112286
Hom.:
AF XY:
AC XY:
33
AN XY:
59458
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000409 AC: 569AN: 1390038Hom.: 0 Cov.: 33 AF XY: 0.000399 AC XY: 273AN XY: 685004
GnomAD4 exome
AF:
AC:
569
AN:
1390038
Hom.:
Cov.:
33
AF XY:
AC XY:
273
AN XY:
685004
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000120 AC: 18AN: 150136Hom.: 0 Cov.: 33 AF XY: 0.0000954 AC XY: 7AN XY: 73360
GnomAD4 genome
AF:
AC:
18
AN:
150136
Hom.:
Cov.:
33
AF XY:
AC XY:
7
AN XY:
73360
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
MN1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 10, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 25, 2021 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at